Compare GANX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GANX | PRPL |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | 21 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.2M | 76.9M |
| IPO Year | 2021 | 2015 |
| Metric | GANX | PRPL |
|---|---|---|
| Price | $1.85 | $0.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $7.50 | $0.85 |
| AVG Volume (30 Days) | ★ 677.3K | 288.5K |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.46 | ★ 152.75 |
| EPS | N/A | ★ 0.48 |
| Revenue | $55,180.00 | ★ $468,725,000.00 |
| Revenue This Year | N/A | $10.83 |
| Revenue Next Year | N/A | $6.81 |
| P/E Ratio | ★ N/A | $1.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.41 | $0.56 |
| 52 Week High | $4.34 | $1.26 |
| Indicator | GANX | PRPL |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 42.86 |
| Support Level | $1.55 | $0.57 |
| Resistance Level | $2.03 | $0.73 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 41.43 | 35.05 |
Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.